Literature DB >> 28180998

The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer.

Zhi-Hua Zhou1,2,3, Cheng-Dong Ji1,2, Jiang Zhu1, Hua-Liang Xiao4, Hai-Bin Zhao3, You-Hong Cui1,2, Xiu-Wu Bian5,6.   

Abstract

PURPOSE: To evaluate the prognostic value and pathobiological significance of Glasgow microenvironment score (GMS), a parameter based on tumor stroma percentage and inflammatory cell infiltration, in gastric cancer.
METHODS: A total of 225 cases of gastric cancer were histologically reviewed, and GMS was evaluated for each case. The association between GMS and patients' survival was investigated. Then the relationship between GMS and mismatch repair (MMR) status, Epstein-Barr virus (EBV) infection were determined using immunohistochemistry (IHC) and in situ hybridization, and the expression of PD1/PD-L1 was examined. Furthermore, the amount of cancer-associated fibroblasts (CAFs), the content and maturity of collagen components were detected using IHC, Picrosirius Red staining and second harmonic generation imaging.
RESULTS: GMS was significantly associated with clinical outcomes of gastric cancer, and multivariate analysis indicated that GMS was an independent factor (HR 1.725, P = 0.002). Low GMS was a manifestation of better prognosis and inflammatory tumor microenvironment, which was related to MMR deficiency (P = 0.042) and EBV infection (P = 0.032), and within this microenvironment, expression of PD-L1 in carcinoma cells (P = 0.030) or in inflammatory cells (P = 0.029) was significantly higher. In contrast, high GMS linked to a poorer survival and desmoplastic stroma, in which there existed markedly increased CAFs and collagen deposition.
CONCLUSION: GMS can serve as a useful prognostic factor for gastric cancer, and according to GMS, the tumor microenvironment in this cancer type may be partially classified as inflammatory or desmoplastic microenvironment that possesses different pathobiological features.

Entities:  

Keywords:  Gastric cancer; Glasgow microenvironment score; Prognosis; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28180998     DOI: 10.1007/s00432-017-2346-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  38 in total

1.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

2.  Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.

Authors:  Sun Young Kim; Charny Park; Ha-Jung Kim; Jihyun Park; Jinha Hwang; Jong-Il Kim; Min Gew Choi; Sung Kim; Kyoung-Mee Kim; Myung-Soo Kang
Journal:  Gastroenterology       Date:  2014-09-22       Impact factor: 22.682

3.  Aberrant type I and type III collagen gene expression in human breast cancer in vivo.

Authors:  S Kauppila; F Stenbäck; J Risteli; A Jukkola; L Risteli
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

Review 4.  Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression.

Authors:  Mario A Shields; Surabhi Dangi-Garimella; Amanda J Redig; Hidayatullah G Munshi
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis.

Authors:  Cole R Drifka; Jo Tod; Agnes G Loeffler; Yuming Liu; Gareth J Thomas; Kevin W Eliceiri; W John Kao
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

7.  Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.

Authors:  B W Kang; A N Seo; S Yoon; H I Bae; S W Jeon; O K Kwon; H Y Chung; W Yu; H Kang; J G Kim
Journal:  Ann Oncol       Date:  2015-12-16       Impact factor: 32.976

Review 8.  Building collagen molecules, fibrils, and suprafibrillar structures.

Authors:  David J S Hulmes
Journal:  J Struct Biol       Date:  2002 Jan-Feb       Impact factor: 2.867

9.  Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma.

Authors:  V Baldan; R Griffiths; R E Hawkins; D E Gilham
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

Review 10.  Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers.

Authors:  Matthew W Conklin; Patricia J Keely
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

View more
  8 in total

1.  Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226.

Authors:  R Rocha; I Rodrigues; I Gullo; G Gonçalves; J Pedro; D Carvalho; F Carneiro; R Soares; S Andrade
Journal:  Porto Biomed J       Date:  2017-09-01

Review 2.  Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.

Authors:  Bita Amir Taghavi; Nazila Alizadeh; Hossein Saeedi; Noora Karim Ahangar; Afshin Derakhshani; Khalil Hajiasgharzadeh; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

3.  Associations between inflammatory gene polymorphisms (TNF-α 308G/A, TNF-α 238G/A, TNF-β 252A/G, TGF-β1 29T/C, IL-6 174G/C and IL-10 1082A/G) and susceptibility to osteosarcoma: a meta-analysis and literature review.

Authors:  Yanhua Jiang; Xiandi Wang; Yi Cheng; Jun Peng; Jiwei Xiao; Dingbo Tang; Ying Yi
Journal:  Oncotarget       Date:  2017-06-29

4.  CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.

Authors:  Keiichiro Kumamoto; Takashi Tasaki; Koji Ohnishi; Michihiko Shibata; Shohei Shimajiri; Masaru Harada; Yoshihiro Komohara; Toshiyuki Nakayama
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

5.  Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer.

Authors:  Shenghan Lou; Jian Zhang; Xin Yin; Yao Zhang; Tianyi Fang; Yimin Wang; Yingwei Xue
Journal:  Front Cell Dev Biol       Date:  2022-01-10

6.  A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer.

Authors:  Rui Wu; Sixuan Guo; Shuhui Lai; Guixing Pan; Linyi Zhang; Huanbing Liu
Journal:  BMC Cancer       Date:  2021-06-10       Impact factor: 4.430

7.  Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.

Authors:  Chen Zheng; Shuaibin Liu; Jiexiong Feng; Xiang Zhao
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

8.  High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis.

Authors:  Mingqiang Liang; Fengqiang Yu; Weidong Wu; Hao Chen; Bin Zheng; Wei Zheng; Yong Zhu; Chun Chen
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.